NEWS

Stay up to date

Virtual Meeting: HIV Prevention Review Meeting 2021, 2 June 2021

Tue, May 25, 2021

The HIV Prevention Program is happening on June 2 from 9:00 AM - 12:00 PM PDT. This program will start with a state-of-the-art update on HIV vaccines by Dr. Larry Corey, followed by an in-depth look at a variety of PrEP strategies, including daily oral and 2-1-1 PrEP, long-acting injectable cabotegravir, and newer agents entering the testing pipeline. You’ll hear from some of the world’s leading researchers on HIV PrEP, and we’ll close with a roundtable discussion, in which we’ll take questions from the audience to discuss the future of HIV prevention. Don’t miss this opportunity to learn about the current state of PrEP and what the future holds for HIV prevention.

Registration fees are waived for healthcare professionals. We welcome everyone involved in HIV prevention to join this important program.

Program Overview
• 09:00 AM PDT: Plenary Talk: HIV Vaccine Landscape
• 09:25 AM PDT: Session 1: Oral PrEP Today – Where Do We Stand?
• 10.00 AM PDT: Session 2: Long-Acting Injectable PrEP
• 11.20 AM PDT: Roundtable Discussion: Where is HIV Prevention Going?

To register visit https://virology.eventsair.com/hivpre2021/registration/Site/Register

Webinar 24 January 2023 06:00 PM EAT - Implementation of Compliant Data Management at Clinical Trial Sites in Africa

Tue, Dec 20, 2022 Clinical Data Management is one of the critical processes in the conduct of clinical trials. The process starts very early in the clinical trial and goes all the way to database closure and data archival. The importance of a compliant data management process could not be overemphasized since data quality denes success in clinical trials. Moreover, all good practices are meant to ensure credible data and the safety of participants. However, data management process is not getting the attention it deserves in LMICs, Sub-Saharan Africa included. In this webinar, we discuss commonly recurring data management issues in LMICs which are detrimental to clinical trial success. The main themes of the webinar include optimal planning in data management, early procedures with an impact on data quality, quality aspects in data management, and other related aspects.

ICGEB South African Women in Biotechnology Programme SAWBP – Postdoctoral Fellowship – CALL OPEN (until 19 May 2023)

Mon, Mar 6, 2023

The ICGEB-SAWBP Postdoctoral Fellowship Scheme, in partnership with the  South African Department of Science and Innovation  and the National Research Foundation  will support South African women researchers holding a PhD degree, in Biotechnology or a related discipline, having outstanding ability, and who will perform hypothesis-driven research.

The SAWBP programme promotes the interaction and mobility of South African women Biotechnology researchers and the ICGEB community, including mobility support to visit other ICGEB Components in Trieste, Italy and New Delhi, India.

The Call is open for applications until 19 May 2023, and offers:

·         Two-year Postdoctoral Fellowship at ICGEB Cape Town

·         Applying the latest techniques and methodologies to the applicant’s chosen research topic

·         Opportunities for mentoring, peer-to-peer learning and complementary skills

·         Immersion in a top class international scientific environment

For further information, eligibility, guidelines for application and contact details: https://www.icgeb.org/fellowships/icgeb-south-african-women-in-biotechnology-programme-sawbp-postdoctoral-fellowship-call/

CIRCB contribution to a COVID-19 Molecular Diagnostics in Cameroon

Fri, Jul 16, 2021

This project was coordinated by the ICGEB and implemented in partnership with reference testing laboratories in Africa. ICGEB Member States, Cameroon, Ethiopia, Kenya, and Nigeria, have taken part in a pilot study to assess the efficacy of a novel diagnostic tool in diverse settings. Dr Joseph Fokam (TMA2015CDF1027) was the local PI in Cameroon.

This pilot study, performed during the period September 2020-May 2021, contributed to the accuracy in detecting SARS-CoV-2 in resource-limited settings. It evaluated the diagnostic performance of RT-LAMP in terms of intrinsic (sensitivity, specificity) and extrinsic (positive and negative predictive values) characteristics according to SARS-CoV-2 viral load estimates provided by the conventional RT-qPCR in four LMICs of Sub-Saharan Africa. Results from the study show that RT-LAMP represents a formidable alternative to RT-qPCR.  New England BioLabs freely contributed its LAMP technology to the study, and the Bill & Melinda Gates Foundation funded the project (INV – 022816).

To learn more about this exciting project visit https://www.youtube.com/watch?v=F-xSlulkN-4